These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17668546)

  • 1. Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes.
    Greenberg HL; Cohen JL; Rosen T; Orengo I
    J Drugs Dermatol; 2007 Apr; 6(4):452-8. PubMed ID: 17668546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of severe eczema following use of imiquimod 5% cream.
    Taylor CL; Maslen M; Kapembwa M
    Sex Transm Infect; 2006 Jun; 82(3):227-8. PubMed ID: 16731674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases.
    Smith WA; Siegel D; Lyon VB; Holland KE
    Pediatr Dermatol; 2013; 30(6):e157-60. PubMed ID: 22612595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A topical imiquimod-induced oral mucosal lichenoid reaction: a case report.
    Brown RS; Farquharson AA
    J Am Dent Assoc; 2014 Nov; 145(11):1141-5. PubMed ID: 25359646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head.
    Rivers JK; Rosoph L; Provost N; Bissonnette R
    J Cutan Med Surg; 2008; 12(3):97-101. PubMed ID: 18544290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of imiquimod-induced alopecia.
    Conde J; Davis K; Ntuen E; Balmer N; Jones D; McMichael A
    J Dermatolog Treat; 2010 Mar; 21(2):122-4. PubMed ID: 19488918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
    Lebwohl M; Dinehart S; Whiting D; Lee PK; Tawfik N; Jorizzo J; Lee JH; Fox TL
    J Am Acad Dermatol; 2004 May; 50(5):714-21. PubMed ID: 15097955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A; Lebwohl M
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
    Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
    J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
    Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
    J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
    Burnett TJ; English JC; Ferris LK
    J Drugs Dermatol; 2010 Aug; 9(8):1022-4. PubMed ID: 20684157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
    Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
    Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
    Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
    AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5% topical imiquimod tolerance in transplant recipients.
    Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
    Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical imiquimod: mechanism of action and clinical applications.
    Vidal D
    Mini Rev Med Chem; 2006 May; 6(5):499-503. PubMed ID: 16719822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis.
    Chakrabarty AK; Mraz S; Geisse JK; Anderson NJ
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):35-7. PubMed ID: 15692510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinic keratosis treated with an immune response modifier: a case report of six patients.
    Bianchi L; Campione E; Marulli GC; Costanzo A; Chimenti S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():39-41. PubMed ID: 14616813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream.
    Berman B; Ricotti CA; Cazzaniga A; Davis SC
    Dermatol Surg; 2004 May; 30(5):784-6. PubMed ID: 15099325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.